Next Article in Journal
Falling Short: The Contribution of Central Insulin Receptors to Gait Dysregulation in Brain Aging
Next Article in Special Issue
Osteopontin and Cancer: Insights into Its Role in Drug Resistance
Previous Article in Journal
Increased Levels of HbA1c in Individuals with Type 2 Diabetes and Depression: A Meta-Analysis of 34 Studies with 68,398 Participants
Previous Article in Special Issue
The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Prevention of Initial Bacterial Attachment by Osteopontin and Other Bioactive Milk Proteins

by
Mathilde Frost Kristensen
1,
Esben Skipper Sørensen
2,
Yumi Chokyu Del Rey
1 and
Sebastian Schlafer
1,*
1
Department of Dentistry and Oral Health, Section for Oral Ecology and Caries Control, Aarhus University, 8000 Aarhus, Denmark
2
Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus, Denmark
*
Author to whom correspondence should be addressed.
Biomedicines 2022, 10(8), 1922; https://doi.org/10.3390/biomedicines10081922
Submission received: 22 June 2022 / Revised: 1 August 2022 / Accepted: 3 August 2022 / Published: 9 August 2022
(This article belongs to the Special Issue 30 Years of OPN Milestones and Future Avenues)

Abstract

:
A considerable body of work has studied the involvement of osteopontin (OPN) in human physiology and pathology, but comparably little is known about the interaction of OPN with prokaryotic cells. Recently, bovine milk OPN has been proposed as a therapeutic agent to prevent the build-up of dental biofilms, which are responsible for the development of caries lesions. Bioactive milk proteins are among the most exciting resources for caries control, as they hamper bacterial attachment to teeth without affecting microbial homeostasis in the mouth. The present work investigated the ability of OPN to prevent the adhesion of three dental biofilm-forming bacteria to saliva-coated surfaces under shear-controlled flow conditions in comparison with the major milk proteins α-lactalbumin, β-lactoglobulin, αs1-casein, β-casein and κ-casein, as well as crude milk protein. OPN was the most effective single protein to reduce the adhesion of Actinomyces naeslundii, Lactobacillus paracasei subsp. paracasei and Streptococcus mitis. β-casein and crude milk protein also had a pronounced effect on all three species, which suggests binding to different microbial surface structures rather than the blocking of a specific bacterial adhesin. Bioactive milk proteins show potential to delay harmful biofilm formation on teeth and hence the onset of biofilm-related oral disease.

Graphical Abstract

1. Introduction

Osteopontin (OPN) is a highly phosphorylated protein present in most mammalian tissues and body fluids, with the highest concentration found in milk [1]. A considerable body of work has explored the multifaceted involvement of OPN in a variety of biological processes, such as cell adhesion, migration and survival, bone remodeling, inflammation and wound-healing [2]. Much less is known about the interaction of OPN with microbial cells. The protein binds avidly to a range of different bacteria, and it has been shown to act as an opsonin that promotes macrophage phagocytosis during bone repair [3]. In the oral cavity, the high affinity of OPN for bacterial cells may be exploited for therapeutic purposes. The administration of OPN isolated from bovine milk has been shown to hamper bacterial adhesion, which delays biofilm formation on teeth and may reduce the occurrence of dental caries or periodontal disease [4,5,6].
Dental caries and periodontitis are amongst the most prevalent diseases of humankind, with significant economic and health impacts worldwide [7]. Both conditions can be prevented by minimizing biofilm accumulation on tooth surfaces, which is currently achieved by mechanical cleaning and antimicrobial adjuncts [8]. Antimicrobial agents seek to kill pathogenic bacteria in dental biofilms, but they also affect commensal microorganisms on soft tissues that contribute to microbial homeostasis. The indiscriminate killing of these commensal bacteria may lead to a disequilibrium in the oral microbiota and a higher risk of developing systemic diseases, such as diabetes and hypertension [9]. Research is therefore focusing on novel strategies for biofilm control that aim at interfering with the mechanisms of biofilm formation instead of simply eradicating oral microorganisms.
Milk products have repeatedly been reported to have caries-preventive properties, and part of this effect may be due to the action of milk proteins [10]. Other than OPN, α-lactalbumin, β-lactoglobulin and several proteins from the casein family have been shown to reduce bacterial attachment in different studies [11,12,13,14,15,16]. However, in most investigations, bacterial adhesion was tested during static incubation with a saliva-free inoculation medium, and hence under conditions that did not accurately mimic the situation in the mouth, where bacterial attachment takes place under constant saliva flow.
The aim of the present work was therefore to investigate the effects of OPN and the principal milk proteins α-lactalbumin, β-lactoglobulin, αs1-casein, β-casein and κ-casein, as well as crude milk protein, on bacterial adhesion in a shear-controlled microfluidic device [17] providing a salivary flow rate representative of the oral cavity [18]. To cover a range of different dental biofilm species, the primary colonizers Streptococcus mitis and Actinomyces naeslundii, as well as the cariogenic Lactobacillus paracasei subsp. paracasei, were chosen for the experiments. The null hypothesis was that none of the investigated proteins would reduce bacterial adhesion of any of the three tested strains compared to control treatment with phosphate-buffered saline (PBS).

2. Materials and Methods

2.1. Purification of Milk Proteins

Skim milk protein was prepared by first removing the milk fat from fresh bovine milk by centrifugation at 4200× g. Thereafter the skimmed milk was dialysed against Millipore water over night in a dialysis tube with cut-off of 12 kDa (Medicel Mebranes Ltd., London, UK) to remove lactose and other small non-protein material, followed by freeze-drying. The caseins αs1-, β- and κ-casein were purified from fresh bovine milk by size exclusion and cation exchange chromatography, as described previously [19,20]. α-lactalbumin and β-lactoglobulin were purified from a whey protein isolate (Arla Foods Ingredients Group P/S, Viby J, Denmark) by reverse-phase HPLC on a Vydac C18 column (The Separations Group, Hesperia, CA, USA). The protein was separated in 0.1% trifluoroacetic acid (TFA; Sigma Aldrich, Søborg, Denmark) (Buffer A) and eluted with a gradient of 60% acetonitrile (Sigma Aldrich) in 0.1% TFA (buffer B) (Gradient: 0–5 min, 0% B; 5–65 min, 98%B; 65–70 min, 98% B; 70–72 min, 0% B). The column was operated at a flowrate of 0.85 mL/min at 40 °C and the proteins were monitored in the effluent by measuring the absorbance at 226 nm. The identity and purity of the proteins was determined by Tris-tricine gel electrophoresis and the fractions of interest were pooled and lyophilized. OPN was provided by Arla Foods Ingredients Group P/S (Lacprodan® OPN-10; Arla Foods Ingredients Group P/S, Viby J, Denmark) with 99.5% purity of the protein component [21].

2.2. Bacterial Culture

A. naeslundii AK 6, L. paracasei subsp. paracasei DSM 20020 and S. mitis SK 24 were grown on blood agar plates (Statens Serum Institut, Copenhagen, Denmark) at 35 °C under aerobic conditions. Prior to adhesion experiments, organisms were transferred to Todd-Hewitt broth (THB, Roth, Karlsruhe, Germany) and cultivated at 35 °C until early stationary phase.

2.3. Bacterial Adhesion

Adhesion experiments were performed using 24-channel microfluidic flow cells with a polydimethylsiloxane surface (Bioflux EZ, fluxion Biosciences, San Franscisco, CA, USA). Stimulated saliva, processed as described by de Jong et al. [22], was diluted with PBS (1:2), titrated to pH 7 and flushed through the channels for 5 min with a flow rate of 100 µL/h (1 dyn/cm2). Thereafter, a salivary pellicle was allowed to form for 30 min under static conditions at 35 °C. Bacterial cultures were washed in fresh THB (pH 7; 4696 g, 5 min), adjusted to an optical density of 0.5 (550 nm) and mixed with three parts of salivary solution. Proteins were thawed at room temperature, pasteurized for 20 min at 80 °C in a water bath and added to the bacterial suspensions, yielding a final concentration of 50 µM. The molecular mass of the milk proteins was calculated from their amino acid sequences (GPMAW V.13.02; Lighthouse Data, Odense, Denmark). For total milk protein an average molecular proteins mass of 21 KDa was used (based on 80% casein and 20% whey proteins with β-lactoglobulin being the dominant whey protein component). PBS was used as the negative control. The bacterial suspensions were then injected into the channels and a flow rate of 10 µL/h (0.1 dyn/cm2) was applied for 1 h, at 35 °C. Thereafter, PBS was flushed through the channels for 30 min (100 µL/h; 1 dyn/cm2) to remove non-adherent cells. Experiments were carried out in biological triplicates.

2.4. Quantification of Bacterial Adhesion

Adhering bacteria were imaged in the viewing chamber of the flow channels using a bright-field microscope (Zeiss Axio Vert A1, Jena, Germany) equipped with a 40× objective (EC Plan-NEOFLUAR, Zeiss, Jena, Germany). Per channel, nine images (1920 × 1440 pixels) were acquired in different fields of view. The images were cropped to 1440 × 960 pixels, manually cleared for artefacts and segmented in the software daime (V2.2.3) [23] based on intensity thresholding. In each image, the area covered by bacteria was calculated.

2.5. Statistical Analysis

The average area coverage was calculated for each bacterial strain and treatment and normalized to control treatment (PBS). The data were log-transformed and their normal distribution and homogeneity of variance were checked with Shapiro–Wilk and Levene’s tests, respectively. One-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test was used to compare each of the treatments to the control group, for each of the bacterial strains. All statistical analysis were performed using the software R (V.4.4.1) [24] with the significance level (α) set at 0.05.

3. Results

All purified milk proteins were estimated to be >95% pure judged by Tris-tricine gel electrophoresis and/or reverse-phase chromatography. All three employed bacterial species adhered well to the flow cells when treated with the negative control PBS. Compared to PBS treatment, the adhesion of L. paracasei subsp. paracasei and S. mitis was significantly reduced by OPN, αs1-casein, β-casein, β-lactoglobulin and crude milk protein, with the most pronounced effects observed for OPN and β-casein. In contrast, the attachment of A. naeslundii was only affected by OPN and crude milk protein (Figure 1). κ-casein and α-lactalbumin did not significantly reduce the number of adhering cells for any of the tested organisms. The null hypothesis was thus partly rejected. Representative microscopy images are shown in Figure 2.

4. Discussion

This work aimed to compare the ability of OPN to prevent bacterial adhesion to saliva-coated surfaces with the principal milk proteins αs1-casein, β-casein, κ-casein, α-lactalbumin and β-lactoglobulin, as well as crude milk protein. Compared to most hitherto published studies on the anti-adhesive properties of milk proteins, we mimicked the conditions of bacterial attachment more closely, by providing a shear-controlled salivary flow with a rate that matches the one in the oral cavity [18]. Bacteria could thus not attach after passive sedimentation to the saliva-covered substrate but had to adhere actively against the medium flow. The molar concentration (50 µM) for all employed proteins was chosen based on previous experiments that had demonstrated a significant but not a maximum effect for 46 µM of OPN [4]. Other studies investigating the effect of milk proteins on bacterial attachment have operated with similar concentrations [11,14,25].
Our work confirmed the anti-adhesive effect of OPN, which was significant for all tested bacterial strains. Κ-casein, in contrast, did not reduce bacterial adhesion, which is in disagreement with some previously published reports [15,26] but in line with previous results of our group on casein glycomacropeptide (CGMP), the C-terminal fragment of κ-casein. The observed discrepancy may be explained by differences in the experimental setup. Both Vacca-Smith et al. and Schüpbach et al. tested bacterial adhesion under static conditions using higher concentrations of κ-casein (≥200 µM), which was added prior to bacterial inoculation and hence incorporated into the salivary pellicle.
In the present study, all other proteins reduced the amount of adhering S. mitis and L. paracasei subsp. paracasei to some extent, although the difference did not reach the level of statistical significance for α-lactalbumin. Streptococcus spp. and Lactobacillus spp. both bind salivary receptors via cell-wall attached serine-rich repeat proteins (SSRPs) [27], but the fact that inhibition was achieved by different milk proteins suggests an unspecific mode of action rather than a targeted binding to particular bacterial adhesins. OPN has previously been shown to confer hydrophilicity to bacterial surfaces [5], and hydrophilic bacteria have repeatedly been demonstrated to be less capable of attaching to saliva/dental tissues [28,29,30,31]. The same mechanism may explain the reduced bacterial attachment upon treatment with other milk proteins, most of which possess strongly hydrophilic domains [32]. Future work may investigate the binding of the major milk proteins to different oral biofilm formers and their effect on surface hydrophobicity.
Contrary to Lactobacillus spp. and most Streptococci, A. naeslundii possesses type I fimbria, long (~700 nm) cell appendages that mediate binding to statherin and proline-rich proteins (PRPs) [33]. Type I fimbria are thus involved in binding to saliva-coated surfaces [34,35], which was illustrated by an unusually long rupture length in atomic force microscopy (AFM) retraction experiments [4]. Neither αs1-casein, nor α-lactalbumin or β-lactoglobulin had any noteworthy effect on the adhesion of A. naeslundii. β-casein reduced the number of attached cells but not significantly. The effect of OPN was significant, but a previous study had shown that Actinomyces spp. required higher concentrations to prevent adhesion than Streptococci [4]. It is conceivable that A. naeslundii’s fimbriae offer fewer binding sites for milk proteins and that they penetrate the hydrophilic barrier on the residual cell surface. The theory is supported by rodent experiments, which showed that treatment with caseinate or skim milk shifted the microbial composition in plaque towards Actinomyces [36].
Interestingly, the effect of treatment with skim milk protein almost matched the one of OPN for all strains in the present study. Since caseins and β-lactoglobulin constitute the bulk of the protein mixture [37] and OPN is only present in negligible amounts, these results suggest a synergistic action of several milk proteins on different bacterial adhesins. Future work may investigate the exact mechanisms by which milk proteins bind different bacteria and identify a product with an optimal composition to hamper bacterial attachment to dental tissues.
In summary, this work demonstrates the ability of different milk proteins to reduce bacterial adhesion to saliva-coated surfaces, with OPN being the most effective single protein. The administration of milk proteins as part of oral care is a promising ecologic approach that may delay the formation of dental biofilms and the onset of biofilm-related diseases without harmful side effects on the commensal oral microbiota.

Author Contributions

Conceptualization, S.S., M.F.K. and E.S.S.; methodology, S.S., M.F.K. and E.S.S.; formal analysis, S.S. and Y.C.D.R.; investigation, M.F.K., S.S. and E.S.S.; resources: S.S. and E.S.S.; writing—original draft preparation, S.S. and Y.C.D.R.; writing—review and editing, M.F.K., E.S.S., S.S. and Y.C.D.R.; visualization: S.S. and Y.C.D.R.; supervision, S.S.; project administration, S.S.; funding acquisition, S.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was partially funded by Arla Foods Ingredients Group P/S (Viby J, Denmark).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors would like to thank Javier E. Garcia, Anni Bojsen and Lise Møller Fogh for excellent technical assistance.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Bruun, S.; Jacobsen, L.N.; Ze, X.; Husby, S.; Ueno, H.M.; Nojiri, K.; Kobayashi, S.; Kwon, J.; Liu, X.; Yan, S.; et al. Osteopontin levels in human milk vary across countries and within lactation period: Data from a multicenter study. J. Pediatr. Gastroenterol. Nutr. 2018, 67, 250–256. [Google Scholar] [CrossRef] [PubMed]
  2. Icer, M.A.; Gezmen-Karadag, M. The multiple functions and mechanisms of osteopontin. Clin. Biochem. 2018, 59, 17–24. [Google Scholar] [CrossRef] [PubMed]
  3. Schack, L.; Stapulionis, R.; Christensen, B.; Kofod-Olsen, E.; Skov Sørensen, U.B.; Vorup-Jensen, T.; Sørensen, E.S.; Höllsberg, P. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J. Immunol. 2009, 182, 6943–6950. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Kristensen, M.F.; Zeng, G.; Neu, T.R.; Meyer, R.L.; Baelum, V.; Schlafer, S. Osteopontin adsorption to Gram-positive cells reduces adhesion forces and attachment to surfaces under flow. J. Oral Microbiol. 2017, 9, 1379826. [Google Scholar] [CrossRef]
  5. Schlafer, S.; Meyer, R.L.; Sutherland, D.S.; Städler, B. Effect of osteopontin on the initial adhesion of dental bacteria. J. Nat. Prod. 2012, 75, 2108–2112. [Google Scholar] [CrossRef]
  6. Schlafer, S.; Raarup, M.K.; Wejse, P.L.; Nyvad, B.; Städler, B.M.; Sutherland, D.S.; Birkedal, H.; Meyer, R.L. Osteopontin reduces biofilm formation in a multi-species model of dental biofilm. PLoS ONE 2012, 7, e41534. [Google Scholar] [CrossRef]
  7. Bernabe, E.; Marcenes, W.; Hernandez, C.R.; Bailey, J.; Abreu, L.G.; Alipour, V.; Amini, S.; Arabloo, J.; Arefi, Z.; Arora, A.; et al. Global, regional, and national levels and trends in burden of oral conditions from 1990 to 2017: A systematic analysis for the global burden of disease 2017 study. J. Dent. Res. 2020, 99, 362–373. [Google Scholar] [CrossRef]
  8. Jafer, M.; Patil, S.; Hosmani, J.; Bhandi, S.H.; Chalisserry, E.P.; Anil, S. Chemical plaque control strategies in the prevention of biofilm-associated oral diseases. J. Contemp. Dent. Pract. 2016, 17, 337–343. [Google Scholar] [CrossRef]
  9. Goh, C.E.; Trinh, P.; Colombo, P.C.; Genkinger, J.M.; Mathema, B.; Uhlemann, A.-C.; LeDuc, C.; Leibel, R.; Rosenbaum, M.; Paster, B.J.; et al. Association between nitrate-reducing oral bacteria and cardiometabolic outcomes: Results from ORIGINS. J. Am. Heart Assoc. 2019, 8, e013324. [Google Scholar] [CrossRef]
  10. Aimutis, W.R. Bioactive properties of milk proteins with particular focus on anticariogenesis. J. Nutr. 2004, 134, 989S–995S. [Google Scholar] [CrossRef] [Green Version]
  11. Danielsson Niemi, L.; Hernell, O.; Johansson, I. Human milk compounds inhibiting adhesion of mutans streptococci to host ligand-coated hydroxyapatite in vitro. Caries Res. 2009, 43, 171–178. [Google Scholar] [CrossRef]
  12. Cheaib, Z.; Rakmathulina, E.; Lussi, A.; Eick, S. Impact of Acquired Pellicle Modification on Adhesion of Early Colonizers. Caries Res. 2015, 49, 626–632. [Google Scholar] [CrossRef] [Green Version]
  13. Oho, T.; Mitoma, M.; Koga, T. Functional domain of bovine milk lactoferrin which inhibits the adherence of Streptococcus mutans cells to a salivary film. Infect. Immun. 2002, 70, 5279–5282. [Google Scholar] [CrossRef] [Green Version]
  14. Neeser, J.R.; Golliard, M.; Woltz, A.; Rouvet, M.; Dillmann, M.L.; Guggenheim, B. In vitro modulation of oral bacterial adhesion to saliva-coated hydroxyapatite beads by milk casein derivatives. Oral Microbiol. Immunol. 1994, 9, 193–201. [Google Scholar] [CrossRef]
  15. Schüpbach, P.; Neeser, J.R.; Golliard, M.; Rouvet, M.; Guggenheim, B. Incorporation of caseinoglycomacropeptide and caseinophosphopeptide into the salivary pellicle inhibits adherence of mutans streptococci. J. Dent. Res. 1996, 75, 1779–1788. [Google Scholar] [CrossRef] [Green Version]
  16. Vacca Smith, A.M.; Bowen, W.H. The effects of milk and kappa-casein on salivary pellicle formed on hydroxyapatite discs in situ. Caries Res. 2000, 34, 88–93. [Google Scholar] [CrossRef]
  17. Benoit, M.R.; Conant, C.G.; Ionescu-Zanetti, C.; Schwartz, M.; Matin, A. New device for high-throughput viability screening of flow biofilms. Appl. Environ. Microbiol. 2010, 76, 4136–4142. [Google Scholar] [CrossRef] [Green Version]
  18. Dawes, C.; Watanabe, S.; Biglow-Lecomte, P.; Dibdin, G.H. Estimation of the velocity of the salivary film at some different locations in the mouth. J. Dent. Res. 1989, 68, 1479–1482. [Google Scholar] [CrossRef]
  19. Rasmussen, L.K.; Petersen, T.E. Purification of disulphide-linked alpha s2- and kappa-casein from bovine milk. J. Dairy Res. 1991, 58, 187–193. [Google Scholar] [CrossRef]
  20. Rasmussen, L.K.; Højrup, P.; Petersen, T.E. The multimeric structure and disulfide-bonding pattern of bovine kappa-casein. Eur. J. Biochem. 1992, 207, 215–222. [Google Scholar] [CrossRef]
  21. Turck, D.; Castenmiller, J.; de Henauw, S.; Hirsch-Ernst, K.I.; Kearney, J.; Maciuk, A.; Mangelsdorf, I.; McArdle, H.J.; Naska, A.; Pelaez, C.; et al. Safety of bovine milk osteopontin as a Novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2022, 20, e07137. [Google Scholar] [CrossRef]
  22. de Jong, M.H.; van der Hoeven, J.S.; van OS, J.H.; Olijve, J.H. Growth of oral Streptococcus species and Actinomyces viscosus in human saliva. Appl. Environ. Microbiol. 1984, 47, 901–904. [Google Scholar] [CrossRef] [Green Version]
  23. Daims, H.; Lücker, S.; Wagner, M. daime, a novel image analysis program for microbial ecology and biofilm research. Environ. Microbiol. 2006, 8, 200–213. [Google Scholar] [CrossRef]
  24. R Core Team. The R Project for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2021. [Google Scholar]
  25. Reynolds, E.C.; Wong, A. Effect of adsorbed protein on hydroxyapatite zeta potential and Streptococcus mutans adherence. Infect. Immun. 1983, 39, 1285–1290. [Google Scholar] [CrossRef] [Green Version]
  26. Vacca-Smith, A.M.; van Wuyckhuyse, B.C.; Tabak, L.A.; Bowen, W.H. The effect of milk and casein proteins on the adherence of Streptococcus mutans to saliva-coated hydroxyapatite. Arch. Oral Biol. 1994, 39, 1063–1069. [Google Scholar] [CrossRef]
  27. Latousakis, D.; MacKenzie, D.A.; Telatin, A.; Juge, N. Serine-rich repeat proteins from gut microbes. Gut Microbes 2020, 11, 102–117. [Google Scholar] [CrossRef]
  28. Busscher, H.J.; van der Mei, H.C. Physico-chemical interactions in initial microbial adhesion and relevance for biofilm formation. Adv. Dent. Res. 1997, 11, 24–32. [Google Scholar] [CrossRef]
  29. McNab, R.; Jenkinson, H.F. Gene disruption identifies a 290 kDa cell-surface polypeptide conferring hydrophobicity and coaggregation properties in Streptococcus gordonii. Mol. Microbiol. 1992, 6, 2939–2949. [Google Scholar] [CrossRef]
  30. Morris, E.J.; Ganeshkumar, N.; McBride, B.C. Cell surface components of Streptococcus sanguis: Relationship to aggregation, adherence, and hydrophobicity. J. Bacteriol. 1985, 164, 255–262. [Google Scholar] [CrossRef] [Green Version]
  31. Jenkinson, H.F. Genetic analysis of adherence by oral streptococci. J. Ind. Microbiol. 1995, 15, 186–192. [Google Scholar] [CrossRef]
  32. Głąb, T.K.; Boratyński, J. Potential of casein as a carrier for biologically active agents. Top. Curr. Chem. 2017, 375, 71. [Google Scholar] [CrossRef] [Green Version]
  33. Hallberg, K.; Holm, C.; Ohman, U.; Strömberg, N. Actinomyces naeslundii displays variant fimP and fimA fimbrial subunit genes corresponding to different types of acidic proline-rich protein and beta-linked galactosamine binding specificity. Infect. Immun. 1998, 66, 4403–4410. [Google Scholar] [CrossRef] [PubMed]
  34. Li, T.; Khah, M.K.; Slavnic, S.; Johansson, I.; Strömberg, N. Different type 1 fimbrial genes and tropisms of commensal and potentially pathogenic Actinomyces spp. with different salivary acidic proline-rich protein and statherin ligand specificities. Infect. Immun. 2001, 69, 7224–7233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Gibbons, R.J.; Hay, D.I.; Cisar, J.O.; Clark, W.B. Adsorbed salivary proline-rich protein 1 and statherin: Receptors for type 1 fimbriae of Actinomyces viscosus T14V-J1 on apatitic surfaces. Infect. Immun. 1988, 56, 2990–2993. [Google Scholar] [CrossRef] [Green Version]
  36. Guggenheim, B.; Schmid, R.; Aeschlimann, J.M.; Berrocal, R.; Neeser, J.R. Powdered milk micellar casein prevents oral colonization by Streptococcus sobrinus and dental caries in rats: A basis for the caries-protective effect of dairy products. Caries Res. 1999, 33, 446–454. [Google Scholar]
  37. Pereira, P.C. Milk nutritional composition and its role in human health. Nutrition 2014, 30, 619–627. [Google Scholar] [CrossRef]
Figure 1. Effect of osteopontin (OPN), αs1-casein (A-Cas), β-casein (B-Cas), κ-casein (K-Cas), α-lactalbumin (A-Lac), β-lactoglobulin (B-Lac) and crude skim milk protein (Milk) on the adhesion of Actinomyces naeslundii (a), Lactobacillus paracasei (b) and Streptococcus mitis (c). Summary data from three biological replicates. For each treatment, adhesion was quantified in nine fields of view. Bars normalized to control group. Error bars = SD. * p < 0.05; ** p < 0.01, *** p < 0.001 (One-way ANOVA followed by Dunnett’s post hoc test).
Figure 1. Effect of osteopontin (OPN), αs1-casein (A-Cas), β-casein (B-Cas), κ-casein (K-Cas), α-lactalbumin (A-Lac), β-lactoglobulin (B-Lac) and crude skim milk protein (Milk) on the adhesion of Actinomyces naeslundii (a), Lactobacillus paracasei (b) and Streptococcus mitis (c). Summary data from three biological replicates. For each treatment, adhesion was quantified in nine fields of view. Bars normalized to control group. Error bars = SD. * p < 0.05; ** p < 0.01, *** p < 0.001 (One-way ANOVA followed by Dunnett’s post hoc test).
Biomedicines 10 01922 g001
Figure 2. Representative bright field images of adherent bacterial cells. Only osteopontin and crude skim milk protein were able to significantly reduce the attachment of all three bacterial species. PBS = phosphate buffered saline. Bars = 20 µm.
Figure 2. Representative bright field images of adherent bacterial cells. Only osteopontin and crude skim milk protein were able to significantly reduce the attachment of all three bacterial species. PBS = phosphate buffered saline. Bars = 20 µm.
Biomedicines 10 01922 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kristensen, M.F.; Sørensen, E.S.; Del Rey, Y.C.; Schlafer, S. Prevention of Initial Bacterial Attachment by Osteopontin and Other Bioactive Milk Proteins. Biomedicines 2022, 10, 1922. https://doi.org/10.3390/biomedicines10081922

AMA Style

Kristensen MF, Sørensen ES, Del Rey YC, Schlafer S. Prevention of Initial Bacterial Attachment by Osteopontin and Other Bioactive Milk Proteins. Biomedicines. 2022; 10(8):1922. https://doi.org/10.3390/biomedicines10081922

Chicago/Turabian Style

Kristensen, Mathilde Frost, Esben Skipper Sørensen, Yumi Chokyu Del Rey, and Sebastian Schlafer. 2022. "Prevention of Initial Bacterial Attachment by Osteopontin and Other Bioactive Milk Proteins" Biomedicines 10, no. 8: 1922. https://doi.org/10.3390/biomedicines10081922

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop